Table of Contents

June 2014, Volume 21, Number 3

Profile

Commentary

    • Frank Weber

    Lymphocytes and thyroid cancer: more to it than meets the eye?

    Endocr Relat Cancer 21 (3) C1-C5, doi:10.1530/ERC-14-0229 first published on 13 May 2014

Reviews

    • Lucas Leite Cunha,
    • Marjory Alana Marcello,
    • and Laura Sterian Ward

    The role of the inflammatory microenvironment in thyroid carcinogenesis

    Endocr Relat Cancer 21 (3) R85-R103, doi:10.1530/ERC-13-0431 first published on 3 December 2013
    • Louis de Mestier,
    • Clarisse Dromain,
    • Gaspard d'Assignies,
    • Jean-Yves Scoazec,
    • Nathalie Lassau,
    • Rachida Lebtahi,
    • Hedia Brixi,
    • Emmanuel Mitry,
    • Rosine Guimbaud,
    • Frédéric Courbon,
    • Michèle d'Herbomez,
    • and Guillaume Cadiot

    Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art

    Endocr Relat Cancer 21 (3) R105-R120, doi:10.1530/ERC-13-0365 first published on 18 December 2013
    • C R C Pieterman,
    • E B Conemans,
    • K M A Dreijerink,
    • J M de Laat,
    • H Th M Timmers,
    • M R Vriens,
    • and G D Valk

    Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis

    Endocr Relat Cancer 21 (3) R121-R142, doi:10.1530/ERC-13-0482 first published on 3 January 2014
    • Delila Gasi Tandefelt,
    • Joost Boormans,
    • Karin Hermans,
    • and Jan Trapman

    ETS fusion genes in prostate cancer

    Endocr Relat Cancer 21 (3) R143-R152, doi:10.1530/ERC-13-0390 first published on 21 March 2014
    • M Fraenkel,
    • M Kim,
    • A Faggiano,
    • W W de Herder,
    • G D Valk,
    • and On behalf of the Knowledge NETwork

    Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature

    Endocr Relat Cancer 21 (3) R153-R163, doi:10.1530/ERC-13-0125 first published on 9 December 2013
    • Wen-Lung Ma,
    • Hsueh-Chou Lai,
    • Shuyuan Yeh,
    • Xiujun Cai,
    • and Chawnshang Chang

    Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis

    Endocr Relat Cancer 21 (3) R165-R182, doi:10.1530/ERC-13-0283 first published on 14 January 2014
    • Yevgeniya Kushchayeva,
    • Kirk Jensen,
    • Kenneth D Burman,
    • and Vasyl Vasko

    Repositioning therapy for thyroid cancer: new insights on established medications

    Endocr Relat Cancer 21 (3) R183-R194, doi:10.1530/ERC-13-0473 first published on 20 January 2014
    • Sarah A Dabydeen and
    • Priscilla A Furth

    Genetically engineered ERα-positive breast cancer mouse models

    Endocr Relat Cancer 21 (3) R195-R208, doi:10.1530/ERC-13-0512 first published on 30 January 2014
    • Lindsay G Carter,
    • John A D'Orazio,
    • and Kevin J Pearson

    Resveratrol and cancer: focus on in vivo evidence

    Endocr Relat Cancer 21 (3) R209-R225, doi:10.1530/ERC-13-0171 first published on 5 February 2014
    OPEN ACCESS ARTICLE
    • Raymond R Y Wong,
    • Michael J Worley, Jr,
    • Tony K H Chung,
    • and Yick Fu Wong

    An update on Müllerian-inhibiting substance: its potential application against ovarian cancer

    Endocr Relat Cancer 21 (3) R227-R233, doi:10.1530/ERC-14-0030 first published on 12 March 2014
    • V Craig Jordan

    Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer

    Endocr Relat Cancer 21 (3) R235-R246, doi:10.1530/ERC-14-0092 first published on 21 March 2014
    • José O Alemán,
    • Azeez Farooki,
    • and Monica Girotra

    Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies

    Endocr Relat Cancer 21 (3) R247-R259, doi:10.1530/ERC-12-0400 first published on 29 January 2014
    • Ales Vicha,
    • David Taieb,
    • and Karel Pacak

    Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma

    Endocr Relat Cancer 21 (3) R261-R277, doi:10.1530/ERC-13-0398 first published on 5 February 2014
    • Su Liu,
    • Shin-Jen Lin,
    • Gonghui Li,
    • Eungseok Kim,
    • Yei-Tsung Chen,
    • Dong-Rong Yang,
    • M H Eileen Tan,
    • Eu Leong Yong,
    • and Chawnshang Chang

    Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases

    Endocr Relat Cancer 21 (3) R279-R300, doi:10.1530/ERC-13-0529 first published on 12 March 2014

Research

    • Constanze Hantel,
    • Sara Jung,
    • Thomas Mussack,
    • Martin Reincke,
    • and Felix Beuschlein

    Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model

    Endocr Relat Cancer 21 (3) 383-394, doi:10.1530/ERC-13-0439 first published on 14 February 2014
    • Tomoko Sekiya,
    • Marcello D Bronstein,
    • Katiuscia Benfini,
    • Viviane C Longuini,
    • Raquel S Jallad,
    • Marcio C Machado,
    • Tatiana D Goncalves,
    • Luciana H Osaki,
    • Leonardo Higashi,
    • Jose Viana-Jr,
    • Claudio Kater,
    • Misu Lee,
    • Sara Molatore,
    • Guilherme Francisco,
    • Roger Chammas,
    • Michel S Naslavsky,
    • David Schlesinger,
    • Patricia Gama,
    • Yeda A O Duarte,
    • Maria Lucia Lebrão,
    • Mayana Zatz,
    • Osorio Meirelles,
    • Bernardo Liberman,
    • Maria Candida B V Fragoso,
    • Sergio P A Toledo,
    • Natalia S Pellegata,
    • and Rodrigo A Toledo

    p27 variant and corticotropinoma susceptibility: a genetic and in vitro study

    Endocr Relat Cancer 21 (3) 395-404, doi:10.1530/ERC-13-0486 first published on 14 February 2014
    • Noriko Kimura,
    • Ryoichi Takayanagi,
    • Nae Takizawa,
    • Eiji Itagaki,
    • Takayuki Katabami,
    • Narihiko Kakoi,
    • Hiromi Rakugi,
    • Yukihiro Ikeda,
    • Akiyo Tanabe,
    • Takeshi Nigawara,
    • Sadayoshi Ito,
    • Itaru Kimura,
    • Mitsuhide Naruse,
    • and The Phaeochromocytoma Study Group in Japan

    Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

    Endocr Relat Cancer 21 (3) 405-414, doi:10.1530/ERC-13-0494 first published on 12 February 2014
    • V H M Tsang,
    • T Dwight,
    • D E Benn,
    • G Y Meyer-Rochow,
    • A J Gill,
    • M Sywak,
    • S Sidhu,
    • D Veivers,
    • C M Sue,
    • B G Robinson,
    • R J Clifton-Bligh,
    • and N R Parker

    Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours

    Endocr Relat Cancer 21 (3) 415-426, doi:10.1530/ERC-13-0519 first published on 12 March 2014
    • Tiantian Liu,
    • Taylor C Brown,
    • C Christofer Juhlin,
    • Adam Andreasson,
    • Na Wang,
    • Martin Bäckdahl,
    • James M Healy,
    • Manju L Prasad,
    • Reju Korah,
    • Tobias Carling,
    • Dawei Xu,
    • and Catharina Larsson

    The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors

    Endocr Relat Cancer 21 (3) 427-434, doi:10.1530/ERC-14-0016
    OPEN ACCESS ARTICLE
    • Yuanyuan Cui,
    • Nagalakshmi Nadiminty,
    • Chengfei Liu,
    • Wei Lou,
    • Chad T Schwartz,
    • and Allen C Gao

    Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells

    Endocr Relat Cancer 21 (3) 435-442, doi:10.1530/ERC-14-0107 first published on 21 March 2014
    • Shahin Assefnia,
    • Keunsoo Kang,
    • Svenja Groeneveld,
    • Daisuke Yamaji,
    • Sarah Dabydeen,
    • Ahmad Alamri,
    • Xuefeng Liu,
    • Lothar Hennighausen,
    • and Priscilla A Furth

    Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer

    Endocr Relat Cancer 21 (3) 443-457, doi:10.1530/ERC-14-0032 first published on 1 April 2014
    • Anton Neschadim,
    • Laura B Pritzker,
    • Kenneth P H Pritzker,
    • Donald R Branch,
    • Alastair J S Summerlee,
    • John Trachtenberg,
    • and Joshua D Silvertown

    Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts

    Endocr Relat Cancer 21 (3) 459-471, doi:10.1530/ERC-14-0088
    • Sheeba Jacob,
    • S Nayak,
    • Gwendolyn Fernandes,
    • R S Barai,
    • S Menon,
    • U K Chaudhari,
    • S D Kholkute,
    • and Geetanjali Sachdeva

    Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer

    Endocr Relat Cancer 21 (3) 473-486, doi:10.1530/ERC-13-0514
    • Salvatore Luca Burgio,
    • Vincenza Conteduca,
    • Cecilia Menna,
    • Elisa Carretta,
    • Lorena Rossi,
    • Emanuela Bianchi,
    • Barbara Kopf,
    • Francesca Fabbri,
    • Dino Amadori,
    • and Ugo De Giorgi

    Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone

    Endocr Relat Cancer 21 (3) 487-493, doi:10.1530/ERC-14-0071 first published on 16 April 2014
    • Jenny Welander,
    • Adam Andreasson,
    • Michael Brauckhoff,
    • Martin Bäckdahl,
    • Catharina Larsson,
    • Oliver Gimm,
    • and Peter Söderkvist

    Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma

    Endocr Relat Cancer 21 (3) 495-504, doi:10.1530/ERC-13-0384 first published on 16 April 2014
    • Shahnawaz Imam,
    • Rodis Paparodis,
    • Deepak Sharma,
    • and Juan Carlos Jaume

    Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity

    Endocr Relat Cancer 21 (3) 505-516, doi:10.1530/ERC-13-0436 first published on 12 March 2014

Research Letter

    • Noriko Kimura,
    • Kazuhiro Takekoshi,
    • Akira Horii,
    • Ryo Morimoto,
    • Tsuneo Imai,
    • Yutaka Oki,
    • Tomohito Saito,
    • Sanae Midorikawa,
    • Tadashi Arao,
    • Chiho Sugisawa,
    • Masanobu Yamada,
    • Yuichi Otuka,
    • Isao Kurihara,
    • Kokichi Sugano,
    • Minoru Nakane,
    • Atsushi Fukuuchi,
    • Takumi Kitamoto,
    • Jun Saito,
    • Tetsuo Nishikawa,
    • and Mitsuhide Naruse

    Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma

    Endocr Relat Cancer 21 (3) L13-L16, doi:10.1530/ERC-13-0530 first published on 21 March 2014
|

This Issue

June 2014; 21 (3)
Cover
  1. Profile
  2. Commentary
  3. Reviews
  4. Research
  5. Research Letter

Find articles in this issue containing these words:

New Articles: issue in progress

  1. July 2018, 25 (7)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most